testosterone

* The available literature suggests BUP may impact male sex hormones to a lesser degree than full-agonist opioids. High-quality research is needed to explore the relationship between BUP and OIH in comparison to full opioid agonists and non-opioid controls...

https://www.urotoday.com/conference-highlights/apccc-2026/168579-apccc-2026-the-importance-of-baseline-testosterone-and-testosterone-recovery-in-high-risk-and-locally-advanced-prostate-cancer.html Taken together, the absence of testosterone recovery seems to be associated with worse overall...

For years, many women have been told that hormones after breast cancer are simply off the table. But what if the evidence is more nuanced than that? In this episode, Dr. Kelly Casperson sits down with medical oncologist, researcher, and sex therapist Dr. Linda Bosserman to discuss estrogen...

* Male sexual symptoms are biologically heterogeneous and clinically nonspecific. Erectile dysfunction, reduced sexual desire, impaired spontaneous erections, and broader androgen-deficiency symptom clusters may arise from vascular, psychogenic, relational, neurological, metabolic, endocrine, or...

Testosterone is the talk of the town. Who should consider treating it and who shouldn't, and can lifestyle changes and supplements really make a difference? In this episode of MAN ALIVE, leading men's health specialist & GP Dr Jeff Foster gives a simple explanation of the benefits and...

Leydig Cell Implants! 11:55-24:00 Testosterone Deficiency Generation & Transcriptomic Validation of hiPSC-Derived Leydig Cells Generation of an Expandable Leydig Progenitor Population Physiologic-Conditions Drive Functional Leydig Maturation 3D Bioprinted...

If you’re searching late at night about erectile dysfunction, low testosterone, libido, or fertility, you’re not alone—and those questions can be an important clue about your overall men’s wellness. In this episode of Baptist HealthTalk, host Dr. Anthony Gonzalez sits down with Dr. Justin...

In this episode, Dr. Kevin Chu and Justin Dubin discuss the recent updates to testosterone therapy labels, debunk myths about prostate cancer risks, and explore the future of testosterone treatment and regulation. They emphasize the importance of evidence-based practice and evolving medical...

In this episode, Dr. Rena Malik sits down with Dr. Martin Miner, Dr. Larry Lipshultz, and Dr. Tobias S. Kohler to unpack the myths and realities of testosterone therapy. The conversation covers who truly benefits from testosterone treatment, how guidelines are evolving, distinctions between...

* To date there's only been one randomized study testing BAT 14:05 Stop & Watch: The TRANSFORMER trial—did BAT actually work? For decades, men with prostate cancer have been told that testosterone is like gasoline on a fire. But what if, under the right conditions, testosterone could...

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss “Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?”

Patiently waiting! Hubert W. Vesper, Ph.D How can laboratories and researchers ensure tests used in patient care and clinical research produces accurate and comparable results...

* Severe energy deficit, sleep disruption, and uncontrollable psychogenic stress suppress hypothalamic gonadotropin-releasing hormone and luteinizing hormone pulsatility, reduce testicular androgen production, and frequently increase sex hormone–binding globulin (SHBG), thereby...

* Testosterone plays an important role in the maintenance of male skeleton. Most studies of testosterone therapy have demonstrated some degree of improvement in BMD * Based on elegant mechanistic studies (discussed below), the current thinking is that both testosterone and estradiol are...

In part one of this men’s health series, Dr. Eve Glazier and Jesse Mills, MD, health sciences clinical professor of urology and director of the Men’s Health Clinic at UCLA Health, examine how symptoms such as erectile dysfunction can offer important insights into overall health. They discuss why...

* Bhasin noted that, like fellow academics and endocrinologists, he has historically been cautious around testosterone therapy. “In the last 5 years or so, we’ve learned a lot more, and I’ve changed my position,” he said. “On one side, it’s very rigid, and on the other, it’s touted as the cure...

Who knew LOL! * Rena Malik, MD brings together leading experts Dr. Helen Bernie, Dr. James Smith, and Chief Medical Advisor of Swim Club Dr. Michael Eisenberg to discuss male infertility, declining sperm counts, and how lifestyle factors impact reproductive health. In this episode, Rena...

In this episode, Dr. Brandon and Dr. Morgentaler talk about the FDA's groundbreaking testosterone label changes, the evolving evidence on testosterone therapy and prostate cancer, and how quality of life should factor into treatment decisions for men with advanced disease. Time stamps...

Sanoj Punnen, MD, highlights the importance of assessing and managing cardiovascular risk when initiating androgen deprivation therapy for patients with prostate cancer.

The FDA's proposed narrowing of the testosterone therapy prostate cancer contraindication to metastatic disease only reflects current clinical evidence, opening the door to testosterone therapy in appropriately selected men with treated localized prostate cancer or on active surveillance, with...

In this episode of AUANews Inside Tract, host Dr. Mark Edney speaks with Dr. Helen Burnie about the FDA’s proposed updates to testosterone therapy labeling and what they could mean for urologists, patients, and the broader field of men’s health. The discussion explores new evidence on...

* For women, clinical discussions are currently underway with the FDA to bring regulatory approval for female-specific testosterone gels and oral formats to the US market within the next two to three years. There is an undeniable buzz around testosterone for women right now. While many...

In conclusion, men with lower testosterone concentrations had higher risk of cancer death, and men with mid-range SHBG or luteinising hormone concentrations had lower risk. Low testosterone concentrations were associated with risk of any fatal or non-fatal incident cancer. Men with lower SHBG or...

* This narrative review integrates randomized and real‑world evidence on TRT‑associated AF, AKI, and PE, translates these signals into practical guidance for patient selection and safety monitoring, and outlines key methodological and mechanistic priorities for future research. In contemporary...

In this episode, Shalin Shah, CEO of Marius Pharmaceuticals and a passionate advocate for testosterone education, shares insights on the misunderstood hormone that impacts both men and women. We dive into myths, testing protocols, treatment options, and the importance of early diagnosis for...

* The survey found that the most commonly reported symptoms over the past year (among those tested) included low energy or fatigue (48%), poor sleep (47%), reduced motivation (34%), low sex drive (28%), mood changes or irritability (27%), brain fog (26%), weight gain (26%), and reduced muscle...

Nature staff discuss preliminary data on the effects of GLP-1 drugs on male fertility, plus a two-year trial of a brain-computer interface. Timestamps 00:18 Brain-computer interface makes a life-changing impactNature: At-home brain implant gives man with motor neuron disease his daily life...

* We devised a formula to calculate predicted total testosterone concentrations, based on meta-analyses of individual participant data from 21,074 men, aged 17-99 years, from nine cohort studies in Australia, Europe and North America of community-dwelling men with testosterone measured using...

https://www.hhs.gov/press-room/fda-requests-updates-testosterone-therapy-labeling.html The U.S. Department of Health and Human Services, through the U.S. Food and Drug Administration (FDA), announced today that it is requesting updates to the prescribing information for testosterone...

Must listen here! Most men think erectile dysfunction is a bedroom problem and low testosterone is just a fact of getting older. This roundtable makes the case that both are early warning lights for your heart, your metabolism, and your long-term health and that ignoring them can cost...